1. Home
  2. MMED vs CZR Comparison

MMED vs CZR Comparison

Compare MMED & CZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MiniMed Group Inc. Common Stock

MMED

MiniMed Group Inc. Common Stock

HOLD

Current Price

$17.91

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Caesars Entertainment Inc.

CZR

Caesars Entertainment Inc.

SELL

Current Price

$29.17

Market Cap

6.0B

ML Signal

SELL

Company Overview

Basic Information
Metric
MMED
CZR
Founded
1983
1937
Country
United States
United States
Employees
N/A
15500
Industry
Medical/Dental Instruments
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.0B
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
MMED
CZR
Price
$17.91
$29.17
Analyst Decision
Buy
Hold
Analyst Count
16
15
Target Price
$25.00
★ $31.27
AVG Volume (30 Days)
★ 11.8M
5.4M
Earning Date
11-10-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $3,102,000,000.00
$1,473,504,000.00
Revenue This Year
$10.84
$3.21
Revenue Next Year
$8.39
$2.49
P/E Ratio
N/A
★ N/A
Revenue Growth
14.25
★ 65.03
52 Week Low
$10.65
$17.86
52 Week High
$24.43
$30.88

Technical Indicators

Market Signals
Indicator
MMED
CZR
Relative Strength Index (RSI) 38.16 24.09
Support Level $14.70 $27.22
Resistance Level $20.88 $29.76
Average True Range (ATR) 0.84 0.13
MACD -0.26 -0.04
Stochastic Oscillator 34.60 6.06

Price Performance

Historical Comparison
MMED
CZR

About MMED MiniMed Group Inc. Common Stock

While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.

About CZR Caesars Entertainment Inc.

Caesars Entertainment's stand-alone portfolio includes about 50 domestic gaming properties across the Las Vegas (48% of 2025 EBITDAR) and regional (49%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2025. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform. The portfolio is set to expand to more than 60 casinos with the proposed acquisition of Caesars by Fertitta Entertainment and its Golden Nugget resorts.

Share on Social Networks: